Astragaloside IV as Potential Antioxidant Against Diabetic Ketoacidosis in Juvenile Mice Through Activating JNK/Nrf2 Signaling Pathway

Klak, 2019, Changes in Gene Expression of Selected Genes in Patients with Type 1 Diabetes and Pancreas Transplant in Peripheral Blood, Transplant Proc, 51, 2787, 10.1016/j.transproceed.2019.04.086 Gu, 2019, High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously, EBioMedicine, 47, 365, 10.1016/j.ebiom.2019.08.036 Kharode, 2019, Care of Children and Adolescents with Diabetes Mellitus and Hyperglycemia in the Inpatient Setting, Curr Diab Rep, 19, 85, 10.1007/s11892-019-1205-7 Garrett, 2019, Recurrent diabetic ketoacidosis and a brief history of brittle diabetes research: contemporary and past evidence in diabetic ketoacidosis research including mortality, mental health and prevention, Diabet Med, 36, 1329, 10.1111/dme.14109 Keshtkar, 2019, Protective effect of nobiletin on isolated human islets survival and function against hypoxia and oxidative stress-induced apoptosis, Sci Rep, 9, 11701, 10.1038/s41598-019-48262-6 Kanikarla-Marie, 2016, Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes, Free Radic Biol Med, 95, 268, 10.1016/j.freeradbiomed.2016.03.020 He, 2018, Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocininduced diabetic rat model, Int J Mol Med, 41, 1078 Nie, 2019, Astragaloside IV protects against hyperglycemia-induced vascular endothelial dysfunction by inhibiting oxidative stress and Calpain-1 activation, Life Sci, 232, 116662, 10.1016/j.lfs.2019.116662 Wang, 2019, Astragaloside IV ameliorates high glucose-induced HK-2 cell apoptosis and oxidative stress by regulating the Nrf2/ARE signaling pathway, Exp Ther Med, 17, 4409 Jiang, 2015, Mechanism of Dose-Dependent Regulation of UBE1L by Polyphenols in Human Bronchial Epithelial Cells, J Cell Biochem, 116, 1553, 10.1002/jcb.25109 Vari, 2015, Protocatechuic Acid Prevents oxLDL-Induced Apoptosis by Activating JNK/Nrf2 Survival Signals in Macrophages, Oxid Med Cell Longev, 2015, 351827, 10.1155/2015/351827 Xu, 2018, Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice, J Microbiol, 56, 838, 10.1007/s12275-018-8327-5 Chen, 2018, Astragalosides IV protected the renal tubular epithelial cells from free fatty acids-induced injury by reducing oxidative stress and apoptosis, Biomed Pharmacother, 108, 679, 10.1016/j.biopha.2018.09.049 Rose, 2015, Simulated diabetic ketoacidosis therapy in vitro elicits brain cell swelling via sodium-hydrogen exchange and anion transport, Am J Physiol Endocrinol Metab, 309, E370, 10.1152/ajpendo.00107.2015 Svart, 2016, Combined Insulin Deficiency and Endotoxin Exposure Stimulate Lipid Mobilization and Alter Adipose Tissue Signaling in an Experimental Model of Ketoacidosis in Subjects With Type 1 Diabetes: A Randomized Controlled Crossover Trial, Diabetes, 65, 1380, 10.2337/db15-1645 Mylona-Karayanni, 2006, Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link, Pediatr Diabetes, 7, 51, 10.1111/j.1399-543X.2006.00147.x Martin-Gallan, 2007, Oxidative stress in childhood type 1 diabetes: Results from a study covering the first 20 years of evolution, Free Radic Res, 41, 919, 10.1080/10715760701435228 Yang, 2019, Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model, Int Immunopharmacol, 75, 105651, 10.1016/j.intimp.2019.05.036 Lee, 2019, Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis, Diabetes Metab Syndr Obes, 12, 1161, 10.2147/DMSO.S209938 Hoffman, 2011, Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis, Brain Res, 1369, 194, 10.1016/j.brainres.2010.10.085 Gui, 2013, Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways, Apoptosis, 18, 409, 10.1007/s10495-013-0801-2 Su, 2019, Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression, Pharmacol Rep, 71, 319, 10.1016/j.pharep.2018.12.008 Li, 2018, Leptin concentration and oxidative stress in diabetic ketoacidosis, Eur J Clin Invest, 48, 10.1111/eci.13006 Vantyghem, 2000, Oxidative markers in diabetic ketoacidosis, J Endocrinol Invest, 23, 732, 10.1007/BF03345062 Mancino, 2011, Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy, Mol Vis, 17, 1298 Qiao, 2017, Astragaloside IV protects rat retinal capillary endothelial cells against high glucose-induced oxidative injury, Drug Des Devel Ther, 11, 3567, 10.2147/DDDT.S152489 Jiang, 2019, Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury from Oxidative Stress by Regulating Succinate, Lysophospholipid Metabolism, and ROS Scavenging System, Oxid Med Cell Longev, 2019, 9137654, 10.1155/2019/9137654 Hu, 2017, Activation of Akt and JNK/Nrf2/NQO1 pathway contributes to the protective effect of coptisine against AAPH-induced oxidative stress, Biomed Pharmacother, 85, 313, 10.1016/j.biopha.2016.11.031